𝔖 Bobbio Scriptorium
✦   LIBER   ✦

1689 – Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized placebo-controlled trial

✍ Scribed by Preuss, U.W.; Bachinskaya, N.; Kaschel, R.; Wong, J.W.; Hoerr, R.; Gavrilova, S.I.

Book ID
122064323
Publisher
Elsevier Science
Year
2013
Tongue
French
Weight
34 KB
Volume
28
Category
Article
ISSN
0924-9338

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of a once-daily form
Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial
✍ Ralf Ihl; Natalia Bachinskaya; Amos D. Korczyn; Veronika Vakhapova; Michael Trib 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 399 KB

## Abstract ## Objective To test the efficacy and safety of a once‐daily formulation of EGb 761 in the treatment of patients with dementia with neuropsychiatric features. ## Methods Multi‐centre trial of 410 outpatients with mild to moderate dementia (Alzheimer's disease, vascular dementia or mi

A double-blind, placebo-controlled, rand
A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults: neuropsychological findings
✍ Joseph A. Mix; W. David Crews Jr. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

There appears to be an absence of large-scaled clinical trials that have examined the efficacy of Ginkgo biloba extract on the neuropsychological functioning of cognitively intact older adults. The importance of such clinical research appears paramount in light of the plethora of products containing